NISA INVESTMENT ADVISORS, LLC
Position in MGX — Metagenomi Therapeutics, Inc.
CIK 937615
ST. LOUIS, MO
Position in MGX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$684
-$143 QoQ
Shares Held
511
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NISA INVESTMENT ADVISORS, LLC holds $80,180,981 across 242 Biotechnology names. MGX ranks #216 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,183 | $25,981,036 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,771 | $15,275,865 | |
| 3 | EXEL |
Exelixis, Inc.
|
107,496 | $4,610,503 | |
| 4 | TECH |
BIO-TECHNE Corp
|
72,813 | $3,805,207 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,357 | $3,095,950 | |
| 6 | INCY |
Incyte Corp
|
31,835 | $2,996,310 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
81,912 | $2,268,962 | |
| 8 | INSM |
INSMED Inc
|
13,447 | $2,198,853 |
All Filings in MGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $684 | 511 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $827 | 511 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,211 | 511 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $929 | 628 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $724 | 533 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,967 | 545 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $17 | 8 | Shares | Sole | 2024-10-24 | |
| No filing history on record for this holder in this stock. | ||||||